Curis Inc Stock Alpha and Beta Analysis

CRIS Stock  USD 4.03  0.08  1.95%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Curis Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Curis over a specified time horizon. Remember, high Curis' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Curis' market risk premium analysis include:
Beta
1.08
Alpha
(0.71)
Risk
3.46
Sharpe Ratio
(0.13)
Expected Return
(0.44)
Please note that although Curis alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Curis did 0.71  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Curis Inc stock's relative risk over its benchmark. Curis Inc has a beta of 1.08  . Curis returns are very sensitive to returns on the market. As the market goes up or down, Curis is expected to follow. At this time, Curis' Price Book Value Ratio is comparatively stable compared to the past year. Price Fair Value is likely to gain to 4.33 in 2024, whereas Book Value Per Share is likely to drop 3.53 in 2024.

Enterprise Value

37.28 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Curis Backtesting, Curis Valuation, Curis Correlation, Curis Hype Analysis, Curis Volatility, Curis History and analyze Curis Performance.

Curis Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Curis market risk premium is the additional return an investor will receive from holding Curis long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Curis. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Curis' performance over market.
α-0.71   β1.08

Curis expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Curis' Buy-and-hold return. Our buy-and-hold chart shows how Curis performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Curis Market Price Analysis

Market price analysis indicators help investors to evaluate how Curis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Curis shares will generate the highest return on investment. By understating and applying Curis stock market price indicators, traders can identify Curis position entry and exit signals to maximize returns.

Curis Return and Market Media

The median price of Curis for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 5.14 with a coefficient of variation of 13.15. The daily time series for the period is distributed with a sample standard deviation of 0.66, arithmetic mean of 5.0, and mean deviation of 0.52. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 2406 shares by James Dentzer of Curis at 3.18 subject to Rule 16b-3
09/19/2024
2
Acquisition by Borgman Anne Elizabeth of 25000 shares of Curis subject to Rule 16b-3
10/11/2024
3
Curis looks to raise 12.1M in private placement
10/29/2024
4
Curis Inc. Stock Surges 5.08 percent Amid Strong Biotech Sector Performance
11/05/2024
5
Earnings call Rigel Pharmaceuticals reports strong Q3 growth, plans expansion
11/08/2024
6
Mersana Therapeutics, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/13/2024
7
Curis GAAP EPS of -1.70 beats by 0.17, revenue of 2.93M beats by 0.56M
11/14/2024
8
Curis, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
9
Curis Q3 Earnings Snapshot - Marketscreener.com
11/21/2024

About Curis Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Curis or other stocks. Alpha measures the amount that position in Curis Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Graham Number70.2253.8327.3726.0
Receivables Turnover3.33.423.593.41

Curis Upcoming Company Events

As portrayed in its financial statements, the presentation of Curis' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Curis' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Curis' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Curis. Please utilize our Beneish M Score to check the likelihood of Curis' management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Curis

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Curis Stock Analysis

When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.